Neurological Complications of COVID-19
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Registration & Credit are FREE of charge.
For Credit, please enroll and complete the evaluation
FacultyRAMI JAMES ASSADI, MD
Department of Neurology
Financial Relationships: Speaker has nothing to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Stroke Center Clinical Conference, April 7, 2020.
Planning committeeAllyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine.
Disclosures: Dr. Zazulia has no financial relationships to disclose.
Renee Van Stavern, MD
Division of Adult Neurology
Consulting/Advisory Committees: American Academy of Neurology/AAN
Authorship: UpToDate (*)
Theresa Human, PharmD, BCPS, FNCS is a Neuroscience Clinical Specialist, Department of Pharmacy, Barnes Jewish-Hospital, St. Louis.
Disclosure: Speakers' Bureaus/Honoraria: UBC Pharma, The Medicines Company, Otsuka America Pharmaceutical.
- Discuss neurological complications of COVID-19
- List risk factors contributing to escalating risk of stroke.
- Prioritize the management and interventions for patients with acute stroke.
- Prioritize the management and interventions for stroke prevention.
Target Audience: This course is designed for primary care physicians, Pediatricians, family and emergency physicians, physician assistants, nurse practitioners and other allied health professionals who encounter covid-19 patients in a health care setting.
Publication Date: July 1, 2020
Expiration Date: July 31, 2020
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .25 ANCC contact hours.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.